发明名称 |
Tálmi við súlfamatóhýdroxamsýrumálmprótínkljúfi |
摘要 |
<p>A sulfamato hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a process for preparing the same, intermediate compounds useful in those syntheses, and a treatment process that comprises administering a contemplated sulfamato hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.</p> |
申请公布号 |
IS6039(A) |
申请公布日期 |
2001.08.07 |
申请号 |
IS20010006039 |
申请日期 |
2001.08.07 |
申请人 |
G.D. SEARLE & CO., CORPORATE PATENT DEPT. |
发明人 |
GARY A. DE CRESCENZO;JOSEPH G. RICO;TERRI L. BOEHM;JEFFERY N. CARROLL;DARREN J. KASSAB;DEBORAH A. MISCHKE |
分类号 |
C07D491/113;A61K;A61K31/4025;A61K31/423;A61K31/427;A61K31/445;A61K31/453;A61K31/454;A61K31/4545;A61K31/496;A61P;A61P1/02;A61P1/04;A61P7/02;A61P9/00;A61P13/12;A61P17/00;A61P19/00;A61P19/02;A61P25/28;A61P27/02;A61P29/00;A61P35/00;A61P35/04;C07D;C07D207/48;C07D211/46;C07D211/66;C07D211/96;C07D295/26;C07D309/08;C07D309/10;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D405/14;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D471/08;C07D491/10;(IPC1-7):C07D405/12 |
主分类号 |
C07D491/113 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|